Get notified when SLDB files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsRed Flags Detected
- Immediate Dilution of $4.30 Per Share (new) — New investors would pay $8.73 per share for stock with an as adjusted net tangible book value of only $4.43 per share, representing immediate dilution of $4.30 per share.
- No Minimum Offering Amount Required (new) — The company is not required to sell any shares under the sales agreement, so the offering may raise significantly less than $200 million or nothing at all.
- 44,408,300 Pre-funded Warrants Outstanding At $0.001 Exercise Price (new) — A large number of pre-funded warrants with a nominal exercise price could be exercised and create substantial additional dilution to new investors.
Solid Biosciences files to sell up to $200M of common stock via ATM; shares last at $8.73
Filed August 6, 2026 · ~1 min read
Key Changes
-
high
Solid Biosciences is offering up to $200 million of common stock in an at-the-market program with Jefferies; no minimum amount is required.
The Offering verify on EDGAR → -
high
The assumed offering price is $8.73 per share, the last sale price on August 5, 2026; actual sales may occur at varying prices.
The Offering verify on EDGAR → -
high
New investors would experience immediate dilution of $4.30 per share, based on an assumed offering price of $8.73 and as adjusted net tangible book value of $4.43 per share.
Dilution verify on EDGAR →
3 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (NTSK 10-Q) is open in full — no account needed.
Partner
Trade SLDB commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Sep 1, 2026 · How we verify